Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia.

Enomoto T, Tatara A, Goda M, Nishizato Y, Nishigori K, Kitamura A, Kamada M, Taga S, Hashimoto T, Ikeda K, Fujii Y.

J Pharmacol Exp Ther. 2019 Dec;371(3):692-702. doi: 10.1124/jpet.119.260869. Epub 2019 Oct 2.

PMID:
31578257
2.

Translational research into species differences of endocrine toxicity via steroidogenesis inhibition by SMP-028--for human safety in clinical study.

Nishizato Y, Imai S, Okahashi N, Yabunaka A, Kunimatsu T, Kikuchi K, Yabuki M.

Toxicol Appl Pharmacol. 2014 May 1;276(3):213-9. doi: 10.1016/j.taap.2014.02.016. Epub 2014 Mar 1.

PMID:
24593921
3.

Effect of SMP-028 on steroidogenesis in rats; mechanism of toxicological events on endocrine organs of rats.

Nishizato Y, Imai S, Yabunaka A, Okahashi N, Kunimatsu T, Yabuki M.

Toxicol In Vitro. 2014 Apr;28(3):397-402. doi: 10.1016/j.tiv.2013.12.005. Epub 2013 Dec 21.

PMID:
24362046
4.

Development of relevant assay system to identify steroidogenic enzyme inhibitors.

Nishizato Y, Imai S, Yabuki M, Kido H, Komuro S.

Toxicol In Vitro. 2010 Mar;24(2):677-85. doi: 10.1016/j.tiv.2009.07.037. Epub 2009 Aug 7.

PMID:
19665544
5.

Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects.

Ieiri I, Suzuki H, Kimura M, Takane H, Nishizato Y, Irie S, Urae A, Kawabata K, Higuchi S, Otsubo K, Sugiyama Y.

Hepatol Res. 2004 Oct;30(2):91-95.

PMID:
15519273
6.

Cytotoxic screening of medicinal and edible plants in Okinawa, Japan, and identification of the main toxic constituent of Rhodea japonica (Omoto).

Masuda T, Oyama Y, Yamamoto N, Umebayashi C, Nakao H, Toi Y, Takeda Y, Nakamoto K, Kuninaga H, Nishizato Y, Nonaka A.

Biosci Biotechnol Biochem. 2003 Jun;67(6):1401-4.

7.

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.

Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, Urae A, Higuchi S, Otsubo K, Sugiyama Y.

Clin Pharmacol Ther. 2003 Jun;73(6):554-65.

PMID:
12811365
8.

Identification of new enzyme biotypes of Helicobacter pylori isolated in Japan.

Matsumoto Y, Yamada M, Fujii Y, Kawai T, Nishizato Y, Uchida Y, Hamashima H, Sasatsu M, Arai T.

Microbios. 1996;85(344):145-9.

PMID:
8676747
9.

[Measurement of electric liver resistivity in chronic liver disease].

Shimizu J, Sakurabayashi S, Sugiura F, Takizawa H, Miyazaki K, Nishizato Y, Saito T, Ashizawa S, Mori R, Yamamoto K, et al.

Nihon Shokakibyo Gakkai Zasshi. 1984 Sep;81(9):2005-11. Japanese. No abstract available.

PMID:
6513123
10.

[Primary biliary cirrhosis with changes in LP-X pattern].

Shimizu J, Yosimatu H, Sakurabayashi S, Sugiura F, Takizawa H, Miyazaki K, Sugimoto E, Nishizato Y, Saito T, Ashizawa S.

Nihon Shokakibyo Gakkai Zasshi. 1983 Sep;80(9):1796-9. Japanese. No abstract available.

PMID:
6655967
11.

[A report on an adult case of type III glycogenosis with primary liver cancer and liver cirrhosis].

Shimizu J, Shiraishi H, Sakurabayashi S, Sugiura F, Takizawa H, Miyazaki K, Matsumoto Y, Nishizato Y, Sato T, Watanabe Y, Masuda S, Watanbe Y, Otaka Y, Sakiyama T, Kitagawa T, Mizuguchi S, Ashizawa S.

Nihon Shokakibyo Gakkai Zasshi. 1982 Dec;79(12):2328-32. Japanese. No abstract available.

PMID:
6300490
12.

[A case of primary macroglobulinemia with generalized amyloidosis (author's transl)].

Shimizu J, Sugiura F, Takahashi H, Hayashi M, Shimada K, Miyazaki K, Nishizato Y, Watanabe E, Nitanai S, Saito T, Ashizawa S, Yamada C, Morinaga K, Sasa H, Ishii N.

Nihon Shokakibyo Gakkai Zasshi. 1979 Aug;76(8):1735-41. Japanese. No abstract available.

PMID:
119883

Supplemental Content

Loading ...
Support Center